Skip to main navigation Skip to search Skip to main content

Advanced drug-delivery approaches in managing P53-mediated lung diseases remodeling

  • Asif Ahmad Bhat
  • , Ritu Gilhotra
  • , Yogendra Singh
  • , Sanjay Sharma
  • , Terezinha De Jesus Andreoli Pinto
  • , Humberto Gomes Ferraz
  • , Sachin Kumar Singh
  • , Kamal Dua
  • , Gaurav Gupta
  • Suresh Gyan Vihar University
  • Maharishi Arvind College of Pharmacy
  • Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management
  • Universidade de São Paulo
  • Lovely Professional University
  • University of Technology Sydney
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
  • Uttaranchal University

Research output: Contribution to journalComment/debate

49 Scopus citations
Original languageEnglish
Pages (from-to)583-587
Number of pages5
JournalNanomedicine
Volume18
Issue number7
DOIs
StatePublished - 1 Mar 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • P53
  • asthma
  • chronic obstructive pulmonary disease
  • drug delivery
  • inflammation
  • lung
  • lung cancer
  • lung injury
  • nanoparticle
  • pulmonary fibrosis

Cite this